Müller, Marcus <br/><br/>
Serum from interferon-β-1b-treated patients with early multiple sclerosis stabilizes the blood-brain barrier in vitro.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  Feb 2012 
 - 236-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1477-0970 
<br/><br/><label>Standard No.: </label>10.1177/1352458511416837  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Adult<br/>Animals<br/>Astrocytes--cytology<br/>Biomarkers--blood<br/>Blood Proteins--pharmacology<br/>Blood-Brain Barrier--drug effects<br/>Cell Line, Transformed<br/>Coculture Techniques<br/>Drug Monitoring--methods<br/>Endothelial Cells--cytology<br/>Female<br/>Humans<br/>Interferon beta-1b<br/>Interferon-beta--therapeutic use<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis--drug therapy<br/>Rats